Corporate Governance24 Sept 2026, 10:21 pm
Aurobindo Pharma Closes Trading Window for Q2 FY27 Results
AI Summary
Aurobindo Pharma Ltd has announced the closure of its trading window for all designated persons, including promoters, directors, and key managerial personnel. This closure is in accordance with the company's Internal Code of Conduct for trading by designated persons. The trading window will be shut from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the second quarter and half-year ending September 30, 2026. The specific date for the board meeting to approve these financial results will be communicated later.
Key Highlights
- Trading window closed from October 1, 2026.
- Closure is for designated persons and their relatives.
- Applies until 48 hours post Q2 FY27 financial results declaration.
- Board meeting date for results to be announced separately.
- Standard corporate governance measure ahead of financial results.
Price Impact
More from AUROPHARMA